The ACME Laboratories Ltd. (DSE:ACMELAB)

Revenue by Segment

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Pharmaceuticals	35.94B	31.93B	26.95B	23.86B	20.77B
Pharmaceuticals Growth	12.54%	18.49%	12.95%	14.87%	9.30%
Total	35.94B	31.93B	26.95B	23.86B	20.77B
Total Growth	12.54%	18.49%	12.95%	14.87%	9.30%

Revenue by Geography

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Bangladesh	38.90B	35.06B	29.47B	26.27B	23.05B
Bangladesh Growth	10.97%	18.97%	12.19%	13.93%	10.57%
Export	2.44B	1.77B	1.60B	1.29B	772.53M
Export Growth	37.73%	11.00%	24.39%	66.39%	-33.69%
Others	965.72K	906.63K	471.13K	726.26K	294.89K
Others Growth	6.52%	92.44%	-35.13%	146.28%	-
Unallocated	-5.41B	-4.90B	-4.12B	-3.69B	-3.06B
Total	35.94B	31.93B	26.95B	23.86B	20.77B
Total Growth	12.54%	18.49%	12.95%	14.87%	9.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error